Aclaris Therapeutics (ACRS) EBIT Margin (2017 - 2026)
Aclaris Therapeutics' EBIT Margin came in at -1487.91% for Q2 2026, down 452.00 percentage points from -1035.90% a year earlier and down 376.08 percentage points from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) EBIT Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported EBIT Margin of -1050.16%, down 176.75 percentage points year-over-year; for FY2025, it was -975.91%, down 217.73 percentage points from FY2024.
- EBIT Margin has declined in each of the last three years, with a five-year change of -190.48 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -758.18% in FY2024 (-446.63 pp), -311.55% in FY2023 (-9.54 pp), -302.01% in FY2022 (+1025.06 pp) and -1327.07% in FY2021 (-541.63 pp).
- The five-year range for quarterly EBIT Margin is -1755.52% (Q4 2025) to -23.03% (Q4 2023).
- Year-over-year, EBIT Margin increased in two of the last eight quarters, with an average year-over-year change of -407.21 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2024 (a gain of 1237.53 percentage points), and the weakest in Q4 2024 (a drop of 1059.10 percentage points).
- Business Quant data shows ACRS's EBIT Margin at -1111.82% (Q1 2026), -1755.52% (Q4 2025) and -519.82% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Aclaris Therapeutics | 759.25 Mn | 759.25 Mn | 1.41 Mn | -1,487.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,487.91% |
| Mar 31, 2026 | -1,111.82% |
| Dec 31, 2025 | -1,755.52% |
| Sep 30, 2025 | -519.82% |
| Jun 30, 2025 | -1,035.90% |
| Mar 31, 2025 | -1,242.89% |
| Dec 31, 2024 | -1,082.13% |
| Sep 30, 2024 | -240.93% |
| Jun 30, 2024 | -464.71% |
| Mar 31, 2024 | -789.45% |
| Dec 31, 2023 | -23.03% |
| Sep 30, 2023 | -340.20% |
| Jun 30, 2023 | -1,702.25% |
| Mar 31, 2023 | -1,183.47% |
| Dec 31, 2022 | -375.07% |
| Sep 30, 2022 | -109.76% |
| Jun 30, 2022 | -1,373.95% |
| Mar 31, 2022 | -1,301.24% |
| Dec 31, 2021 | -1,525.18% |
| Sep 30, 2021 | -1,223.33% |
API Access
Aclaris Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();